A compound (compound X) with antibacterial activity was isolated from early-exponential-phase cultures of the streptomycin producer Streptomyces griseus and from protoplast cultures of the same strain. The protoplast cultures produced a larger amount of compound X than did the young hyphae. Both the mycelia and the protoplasts incorporated '4C-labeled myo-inositol, a precursor of streptomycin, into compound X, which has an amino acid content related to that of the cell wall peptidoglycan of the producer strain. Compound X may contain a streptomycin molecule covalently bound to a cell wall precursor unit, i.e., to a Park nucleotide (J. T. Park, J. Biol. Chem. 194:897-904, 1952), through the glutamic acid of the pentapeptide component.In the last few decades, there has been much speculation (1,5,7,8,12,13) about the biological role of antibiotics. Some of this speculation has been supported by experimental results (1, 12, 13); other speculations were, however, purely hypothetical in nature. When we started to study the biological role of streptomycin, an aminoglycoside-type antibiotic, we found a correlation between cell wall synthesis and antibiotic synthesis (1-3; G. Barabas, Folia Microbiol. 18:266, 1973); various inhibitors of cell wall synthesis increased the production of streptomycin (2).Since both the cell wall and streptomycin contain significant amounts of carbohydrate, we supposed that a common precursor exists for the two biosynthetic pathways. The search for this common precursor resulted in the isolation of a molecule of unknown structure (compound X) possessing antibiotic activity.This article discusses the isolation and exploration of the chemical structure of this compound, which appears to be a covalent complex of streptomycin and the Park nucleotide (11). MATERIALS rpm and 28°C for 50 min to complete protoplast formation. The protoplasts were purified by filtration through cotton wool to remove contaminating mycelial fragments. After centrifugation at 300 x g for 15 min at 4°C, the protoplasts were washed twice with lysozyme-free protoplasting medium (10) and finally suspended in 15 ml of the same medium from which vancomycin was omitted.Compound X. (i) Production by protoplasts. A 3-ml sample of the protoplast suspension (see above) was supplemented with 27 kBq of myo-[U-14C]inositol (1.23 GBq/mmol). This protoplast suspension was incubated at 28°C for 5 h with gentle shaking (250 rpm in a rotatory shaker; New Brunswick Scientific). Compound X was isolated from the supernatant fraction of the incubation mixture after protoplasts had been removed by centrifugation (3,000 x g for 20 min).(ii) Production by mycelia. A 20-mg (wet weight) sample of 18-h-old mycelia was suspended in 15 ml of the medium used for the cultivation of protoplasts (10).The same amount of myo-[U-14C]inositol as used for the protoplast suspension was added, and the incubation conditions were also identical. Compound X was isolated from the supernatant fraction of the mycelial culture.Antibiotic assay. Antibiotic activity w...